ArticlePakistan journal of medical sciences2026
Effectiveness of classification and scoring systems in solitary fibrous tumor prognosis prediction.
Article in Pakistan journal of medical sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: Because thoracic solitary fibrous tumors (SFTs) are rare, there is limited information on their clinical features, treatment, and follow-up. The literature mainly comprises individual case reports. Our study aimed to analyse SFT data to identify prognosis-related factors and to compare the performance of two describing approaches and three risk stratification models. Methodology: We conducted a retrospective review of medical data from 37 patients, including 32 patients with SFT aged 18 years and older who underwent surgical treatment and five patients diagnosed by biopsy at Kocaeli University Hospital between January 2004 and December 2024. Parameters affecting recurrence and survival were investigated, and the effectiveness of existing classification and scoring systems was compared. Results: Factors potentially associated with recurrence included four or more mitoses (10 HPF) (p=0.023), necrosis (p=0.007), at least 10% Ki-67 positivity (p=0.012), malignancy (p=0.046), and tumor size (p=0.022). Relapses were observed only in the malignant group according to the England classification (p=0.046), only in stage-3 according to the de Perrot classification (p=0.161), only in those with scores of three or higher according to the Tapias classification (p=0.036), only in those with scores of two or higher according to the Diebold classification (p=0.021), and all in high-stage groups (p=0.001) according to the Demicco classification. All recurrences occurred at significant or high scores. Conclusions: The Tapias, Diebold, and Demicco scoring systems are highly effective in predicting recurrence and prognosis. However, the modified Demicco system is more advantageous and offers a higher level of assessment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.